Current Opinion in Infectious Diseases

Article	Citations
Update on group A streptococcal vaccine development	56
Aspergillus fumigatus and pan-azole resistance: who should be concerned?	55
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination	52
Current choices of antibiotic treatment for Pseudomonas aeruginosa infections	48
Skin manifestations of Pseudomonas aeruginosa infections	47
Central nervous system infections produced by varicella zoster virus	46
COVID-19 in children: current evidence and key questions	45
Sapovirus: an emerging cause of childhood diarrhea	41
Pediatric acute gastroenteritis associated with adenovirus 40/41 in low-income and middle-income countries	39
New treatment options for multiresistant gram negatives	37
Treatment of multidrug-resistant Gram-negative skin and soft tissue infections	37
Giardiasis treatment: an update with a focus on refractory disease	34
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection	33
Tuberculous meningitis: where to from here?	28
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections	28
Updates on defining and detecting diarrheagenic Escherichia coli pathotypes	27
Antimicrobial-resistant bacteria in international travelers	24
Parental vaccine hesitancy: scope, causes, and potential responses	23
Long COVID in children and adolescents	22
Techniques in bacterial strain typing: past, present, and future	21
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy	20
Infections after anti-CD19 chimeric antigen receptor T-cell therapy for hematologic malignancies: timeline, prevention, and uncertainties	20
Zoonoses and global epidemics	19
Scrub typhus: a reemerging infection	18
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections	18

New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections	18
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	18
MDRO transmission in acute hospitals during the COVID-19 pandemic	17
Choosing antibiotic therapy for severe community-acquired pneumonia	17
Emerging treatment options for cryptosporidiosis	16
Final frontiers of the polio eradication endgame	16
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	16
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	16
Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis	16
Prolonged infusion of beta-lactam antibiotics for Gram-negative infections: rationale and evidence base	16
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	16
Community-acquired pneumonia in chronic obstructive pulmonary disease	15
Subarachnoid neurocysticercosis: emerging concepts and treatment	15
Coronavirus disease 2019 vaccination in transplant recipients	15
Gram-negative endocarditis: disease presentation, diagnosis and treatment	15
The role of multidrug and extensive-drug resistant Gam-negative bacteria in skin and soft tissue infections	14
Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections	14
Fungal infections of the skin and soft tissue	14
New testing guidelines for community-acquired pneumonia	13
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination	13
COVID-19 transmission and the safety of air travel during the pandemic: a scoping review	13
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity	13
Unresolved issues in the identification and treatment of carbapenem-resistant Gram-negative organisms	13
Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials	13
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	12
Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges	12
Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions	12
Bacteriophage therapy as a treatment option for transplant infections	12
Skin manifestations in patients with coronavirus disease 2019	12
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infections	11
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	11
Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients	11
Long-acting injectable HIV therapies: the next frontier	11
Optimizing aerosol delivery of antibiotics in ventilated patients	11
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients	11
Advances in the diagnosis and treatment of latent tuberculosis infection	11
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts	11
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls	10
What is new with hand hygiene?	10
Staphylococcus aureus infections in children	10
Viral meningitis and encephalitis: an update	10
Neurologic aspects of coronavirus disease of 2019 infection	10
Hospital water as the source of healthcare-associated infection and antimicrobial-resistant organisms	10
Mind the gaps: challenges in the clinical management of invasive candidiasis in critically ill patients	10
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	10
Mycobacterial skin infection	10
Respiratory metagenomics: route to routine service	10
Dengue vaccine development: challenges and prospects	10
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection	10
Management dilemmas in Nocardia brain infection	10

Antibiotic treatment of common infections: more evidence to support shorter durations	10
Typhoid fever control in the 21st century: where are we now?	10
Infections associated with the new ‘nibs and mabs’ and cellular therapies	10
Dose optimisation of antibiotics used for meningitis	9
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	9
Echocardiography and FDG-PET/CT scan in Gram-negative bacteremia and cardiovascular infections	9
Frailty in people living with HIV: an update	9
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections	9
Siderophores: a potential role as a diagnostic for invasive fungal disease	9
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	9
Immunotherapeutic approaches to HIV cure and remission	9
Emergence of a novel urogenital-tropic Neisseria meningitidis	9
Neuroradiology of infectious diseases	9
Clinical application of non-coding RNAs in sepsis	9
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	8
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?	8
Hyperammonemia syndrome in immunosuppressed individuals	8
Pneumonia in older adults	8
Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections	8
The role of new antimicrobials for Gram-negative infections in daily clinical practice	8
Brain calcification because of neurocysticercosis: a vast field to be explored	8
CNS infections in HIV	8
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	8
Coronavirus disease 2019 in children	7
mRNA vaccines against respiratory viruses	7
The skin and soft tissue infections in hematological patients	7
Tick-borne encephalitis	7
Bacterial RTX toxins and host immunity	7
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications	7
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions	7
Nontyphoidal Salmonella infections acquired from poultry	7
Arboviral central nervous system infections	7
Biomarkers in sepsis: can they help improve patient outcome?	7
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	7
Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia	7
Neonatal bloodstream infections	7
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	7
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	7
Respiratory syncytial virus infection in the modern era	7
Antibody glycosylation in pregnancy and in newborns: biological roles and implications	7
Managing and preventing exacerbation of bronchiectasis	6
The role of Gram-negative bacteria in skin and soft tissue infections	6
Biomarkers to predict cardiovascular disease in people living with HIV	6
Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient − clinical spectrum and outcome	6
Current management of necrotizing soft-tissue infections	6
The infant pharyngeal microbiomes: origin, impact and manipulation	6
How common is ventilator-associated pneumonia after coronavirus disease 2019?	6
Laboratory-developed test regulation and the immunocompromised patient: uncertainty ahead	6
Prevention strategies for congenital cytomegalovirus infection	6
Congenital Chagas disease: progress toward implementation of pregnancy-based screening	6
Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections	6
When should we use corticosteroids in severe community-acquired pneumonia?	6
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections	6
Unraveling Haemophilus influenzae virulence mechanisms enable discovery of new targets for antimicrobials and vaccines	6
Current opinion in management of septic shock due to Gram-negative bacteria	6
Molecular diagnostic methods for pneumonia: how can they be applied in practice?	6
The intracellular phase of extracellular respiratory tract bacterial pathogens and its role on pathogen-host interactions during infection	6
New antibiotics for the treatment of nonfermenting Gram-negative bacteria	6
Antimicrobial use in central nervous system infections	6
Current international and national guidelines for managing skin and soft tissue infections	6
Drug resistance in Salmonella Typhi: implications for South Asia and travel	6
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	6
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	6
Cytomegalovirus in primary immunodeficiency	6
The microbiota in respiratory tract infections: from association to intervention	6
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy	6
Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome	5
The implications of the COVID-19 pandemic for long term care facilities	5
New management approaches to tuberculosis in people living with HIV	5
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges	5
Central nervous system infections after solid organ transplantation	5
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	5
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?	5
Global health security as it pertains to Zika, Ebola, and COVID-19	5
Pregnancy and malaria: the perfect storm	5
Update on nonantibiotic therapies for acute gastroenteritis	5
The current state of immunization against Gram-negative bacteria in children: a review of the literature	5
Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment	5
Pulmonary infections in the hematopoietic cell transplant patient	5
The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease	5

Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?	5
Antibiotic treatment of acute bacterial skin and skin structure infections	5
Host transcriptional signatures as predictive markers of infection in children	5
Conjunctival cancer in people living with HIV	5
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	5
Recent concepts in fungal involvement in skin and soft tissue infections	4
Anatomical site-specific immunomodulation by bacterial biofilms	4
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	4
Neurodevelopmental outcomes in congenital and perinatal infections	4
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	4
Antiviral therapies for influenza	4
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	4
Beyond personal protective equipment: adjunctive methods for control of healthcare-associated respiratory viral infections	4
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	4
Gastrointestinal manifestations of coronavirus disease 2019	4
Congenital cytomegalovirus infection diagnostics and management	4
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	4
Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts	4
Resistant herpes simplex virus infections – who, when, and what's new?	4
Transplantation for chagas’ disease: closing the knowledge gap	4
Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections	3
Cotrimoxazole and clindamycin in skin and soft tissue infections	3
Machine learning and artificial intelligence for the diagnosis of infectious diseases in immunocompromised patients	3
Updates in central nervous system malaria: literature review and considerations	3
The impact of coronavirus disease 2019 on people with HIV	3
Diagnostic approach and update on encephalitis	3
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	3
The interplay between acute bacterial skin and skin structure infections and depression: a vicious circle of major clinical importance	3
Neurocysticercosis: an update on diagnosis, treatment, and prevention	3
Community-acquired skin and soft-tissue infections in people who inject drugs	3
Contributions of Yersinia pestis outer membrane protein Ail to plague pathogenesis	3
The eternal dilemma of antitoxin antibiotics for skin and soft tissue infection	3
Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children	3
Duration of antimicrobial therapy for Gram-negative infections	3
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	3
New approaches to management of fever and neutropenia in high-risk patients	3
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	3
The future of Clostridioides difficile diagnostics	3
Where was my patient born? The Intersection of tropical medicine and migrant health	3
Sequence-based diagnostics and precision medicine in bacterial and viral infections: from bench to bedside	3
Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children	3
Acute infectious myelopathies	3
Human herpesvirus 8 and Kaposi sarcoma: how should we screen and manage the transplant recipient?	3
New evidence for managing Gram-negative bloodstream infections	3
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?	3
Modeling transmission of pathogens in healthcare settings	3
Burden of influenza in the elderly: a narrative review	3